Lac-Hydrin (ammonium lactate) Lotion, 12%, packaged in 400 g bottles, Rx only, Ranbaxy, Jacksonville, FL 32257 USA, NDC 10631-098-14.
Published February 20, 2013 · Recall initiated: December 27, 2012
Summary
FDA records drug Class III recall D-162-2013, published February 20, 2013 and initiated December 27, 2012. Recalling firm: Ranbaxy Inc.; Status: Terminated; Reported quantity: 4,016 bottles; Lot: Lot #: RB93911, Exp 07/14. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ranbaxy Inc.
- Distributor
- Nationwide and Puerto Rico
- Lot
- Lot #: RB93911, Exp 07/14
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAbsorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. ManufacturedAugust 12, 2015
- FDAAtorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: RanbaxyMarch 5, 2014
- FDALac-Hydrin (ammonium lactate) Cream, 12%, packaged in a) 280 g (2 x 140 g tubes), NDC 10631-099-28; b) 385 gFebruary 20, 2013
- FDA12-Hour Sinus (oxymetazoline hydrochloride) Nasal Spray, 0.05%, 1 FL OZ (30 mL), labeled as a) 12 HOUR SINUSFebruary 20, 2013
- FDAPropranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured forFebruary 20, 2013
- FDAAtorvastatin Calcium Tablets, 40 mg, a) 90 tablets per bottle, b) 500 tablets per bottle, Rx only,December 5, 2012
Questions about this recall
Was Lac-Hydrin (ammonium lactate) Lotion, 12%, packaged in 400 g bottles, Rx only, Ranbaxy, Jacksonville, FL 32257 USA, NDC 10631-098-14. recalled?
Yes. FDA published recall D-162-2013 on February 20, 2013. Reported hazard: Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter